These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transregulation of the alpha2-adrenergic signal transduction pathway by chronic beta-blockade: a novel mechanism for decreased platelet aggregation in patients. Schwencke C; Schmeisser A; Weinbrenner C; Braun-Dullaeus RC; Marquetant R; Strasser RH J Cardiovasc Pharmacol; 2005 Mar; 45(3):253-9. PubMed ID: 15725951 [TBL] [Abstract][Full Text] [Related]
8. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579 [TBL] [Abstract][Full Text] [Related]
9. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding. O'Hara N; Yokota S; Kouchi Y; Ono H Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728 [TBL] [Abstract][Full Text] [Related]
11. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments. Villeneuve A; Berlan M; Lafontan M; Montastruc JL Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047 [TBL] [Abstract][Full Text] [Related]
12. Adrenergic mechanisms associated with the movement of platelets in iridophores from the freshwater goby, Odontobutis obscura. Maeno N; Iga T Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Jun; 102(2):233-7. PubMed ID: 1358536 [TBL] [Abstract][Full Text] [Related]